Angiotensin II receptor blockers: the importance of dose in cardiovascular and renal risk reduction [0.03%]
血管紧张素Ⅱ受体阻断药：剂量在心血管和肾脏危险因素减少中的重要性
Matthew R Weir
Matthew R Weir
Numerous clinical studies have established that angiotensin II receptor blockers are effective as antihypertensive therapy and are well tolerated. Studies demonstrate that adding an angiotensin II receptor blocker to existing antihypertensi...
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in African-American patients with hypertension [0.03%]
高血压患者的血管紧张素转换酶抑制剂和非洲美国患者中的血管紧张素受体拮抗剂
Vasilios Papademetriou,Puneet Narayan,Peter Kokkinos
Vasilios Papademetriou
African-American patients with hypertension are less responsive to blockers of the renin-angiotensin system than white patients. The relative efficacy of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and the ext...
David S Marks,Surrendra Gudapati,L M Prisant et al.
David S Marks et al.
Patients with chest pain/ischemic cardiac disease and normal coronary arteriography are thought to have a benign prognosis despite diminished quality of life. Many patients with hypertension fall into this group, at least in the early stage...
National Kidney Disease Education Program in 2004: a program in evolution [0.03%]
2004年的全国慢性肾病教育计划——一个成长中的项目
Thomas Hostetter,Elisa H Gladstone,Domenic A Sica
Thomas Hostetter
Minoxidil: an underused vasodilator for resistant or severe hypertension [0.03%]
米诺地尔：一种未被充分利用的血管扩张剂，用于难治性或严重高血压患者的治疗
Domenic A Sica
Domenic A Sica
Minoxidil is a direct vasodilator introduced in the early 1970s for the treatment of hypertension. It is capable of reducing blood pressure in most persons with resistant hypertension where therapy has failed with multidrug regimens. Minoxi...
Hypertension in Hispanics [0.03%]
西班牙人的高血压问题
Thomas G Pickering
Thomas G Pickering
Robert A Phillips,John B Kostis
Robert A Phillips
Clinical problems in the management of hypertension 1) Prehypertension: should we treat? 2)The very elderly: how should we treat [0.03%]
高血压的临床问题1）前期高血压：应该治疗吗？2）高龄老人：该如何治疗？
Marvin Moser,Michael H Alderman,Jackson T Wright Jr
Marvin Moser
Following a hypertension symposium in New York, NY, on January 28, 2004, a panel was convened to discuss several issues of interest in the management of hypertension. Dr. Marvin Moser of the Yale University School of Medicine, New Haven, CT...
Maylene Wong,Luigi Tavazzi
Maylene Wong
Symptomatic heart failure interferes with a patient's quality of life (QOL) by limiting his or her ability to perform physical tasks and daily activities and by lowering his or her sense of psychological well-being. Therefore, in addition t...
Lawrence Baruch
Lawrence Baruch
Hypertension is a major risk factor for cardiovascular disease in both young and elderly persons; therefore, good blood pressure control is at the center of improved cardiovascular health. The recently issued seventh report of the Joint Nat...